Published on 10/1/2015 in the Prospect News Structured Products Daily.
New Issue: Bank of Montreal prices $61,000 buffered bullish notes on iShares Nasdaq Biotech
By Susanna Moon
Chicago, Oct. 1 – Bank of Montreal priced $61,000 of 0% buffered bullish enhanced return notes due Sept. 29, 2017 linked to the iShares Nasdaq Biotechnology exchange-traded fund, according to a 424B2 filing with the Securities and Exchange Commission.
The payout at maturity will be par plus 150% of any fund gain, up to a maximum return of 19.5%.
Investors will receive par if the fund falls by up to 10% and will lose 1% for each 1% decline beyond 10%.
BMO Capital Markets Corp. is the agent.
Issuer: | Bank of Montreal
|
Issue: | Buffered bullish enhanced return notes
|
Underlying fund: | iShares Nasdaq Biotechnology ETF
|
Amount: | $61,000
|
Maturity: | Sept. 29, 2017
|
Coupon: | 0%
|
Price: | Par
|
Payout at maturity: | Par plus 150% of any fund gain, capped at 19.5%; par if fund falls by up to 10%; exposure to losses beyond 10%
|
Initial level: | $310.24
|
Pricing date: | Sept. 25
|
Settlement date: | Sept. 30
|
Agent: | BMO Capital Markets Corp.
|
Fees: | 2.3%
|
Cusip: | 06366R2A2
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.